Dr, Department of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Japan
Commentary
Commentary on TP53 Mutated Myeloid Malignancies and Their Treatment Strategy
Author(s): Yasuhito Nannya*
DOI:
10.37421/2165-7831.2023.13.306
Journal of Blood & Lymph received 443 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 